Fortrea Clinical Development Private Limited - Company Profile

It is a pharma private limited company based in Bangalore North, Karnataka, India, established in 2002.
2002 Bangalore North, Karnataka, India Active
Last Updated:
Access Report
About Fortrea Clinical Development Private Limited

Fortrea Clinical Development Private Limited, a active private limited company, was established on 24 September 2002 in Bangalore North, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100KA2002PTC031038. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.24 M.

Formerly known as Omnicare Clinical Research India Private Limited, Covance Clinical Development Private Limited. It upholds a compliant status. Employing 219 professional, Its leadership includes David Howard Cooper (Director), Rishi Raj Sharma (Director). Past directors included David Howard Cooper, Andrew Graham Lambert, Richard John Karbowiak. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sattva Knowledge Court, 2Nd Floor, Wing B, Plot No. 9, Katha No. 299, Sy. No. 77,, Doddenakkundi Phase I Industrial Area, Whitefield Road,, Bangalore North, Karnataka, 560048.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2002PTC031038

  • Registration Number

    031038

  • Incorporation Date

    24 September 2002

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹0.24 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 0.24 M
  • Company Age 23 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -8.49%
  • Profit Growth **** 55.49%
  • Ebitda **** -41.91%
  • Net Worth 18.64%
  • Total Assets **** 13.81%
Company report

Fortrea Clinical Development Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fortrea Clinical Development Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Fortrea Clinical Development Private Limited?
Current Directors
Name Designation Appointment Date Status
David Howard Cooper Director 30 Jun 2023 Current
Rishi Raj Sharma Director 11 Sep 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 25 Sep 2023 Past
Pramod Abcsdd Director 11 Jan 2016 Past
Pramod Abcsdd Director 27 Jun 2012 Past
Pramod Abcsdd Director 04 Dec 2018 Past
Pramod Abcsdd Director 22 Feb 2018 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fortrea Clinical Development.

Fortrea Clinical Development Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.49% decrease. The company also saw a substantial improvement in profitability, with a 55.49% increase in profit. The company's net worth Soared by an impressive increase of 18.64%.

Fortrea Clinical Development revenue growth over time
Fortrea Clinical Development profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -8.49%
*******
*******
*******
*******
Revenue from Operations
*******
 -23.01%
*******
*******
*******
*******
Total Assets
*******
 13.81%
*******
*******
*******
*******
Profit or Loss
*******
 55.49%
*******
*******
*******
*******
Net Worth
*******
 18.64%
*******
*******
*******
*******
EBITDA
*******
 -41.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fortrea Clinical Development?

In 2023, Fortrea Clinical Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Fortrea Clinical Development?

Fortrea Clinical Development has a workforce of 219 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fortrea Clinical Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortrea Clinical Development's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fortrea Clinical Development
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Fortrea Clinical Development Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Fortrea Clinical Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.

  • Director Appointment

    The activity Rishi Raj Sharma was appointed as a Director was appointed as a Director on 11 Sep 2023 & has been associated with this company since 2 years 5 months . was completed.

  • Director Appointment

    The activity David Howard Cooper was appointed as a Director was appointed as a Director on 30 Jun 2023 & has been associated with this company since 2 years 7 months . was completed.

  • Company Incorporation

    Progress on Fortrea Clinical Development Private Limited was registered on 24 Sep 2002 with Roc Bangalore & aged 23 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fortrea Clinical Development Private Limited?

The CIN of Fortrea Clinical Development Private Limited is U73100KA2002PTC031038.

Where is Fortrea Clinical Development Private Limited headquartered?

Fortrea Clinical Development Private Limited is headquartered at Sattva Knowledge Court, 2Nd Floor, Wing B, Plot No. 9, Katha No. 299, Sy. No. 77,, Doddenakkundi Phase I Industrial Area, Whitefield Road,, Bangalore North, Karnataka, 560048.

When was Fortrea Clinical Development Private Limited incorporated?

Fortrea Clinical Development Private Limited was incorporated on 24 September 2002.

Who are the current directors of Fortrea Clinical Development Private Limited?

The current directors of Fortrea Clinical Development Private Limited are

What is the primary industry of Fortrea Clinical Development Private Limited?

The primary industry of Fortrea Clinical Development Private Limited is Professional, Scientific And Technical.

Is Fortrea Clinical Development Private Limited a listed company?

Fortrea Clinical Development Private Limited is unlisted.

What is the capital structure of Fortrea Clinical Development Private Limited?

The authorized capital of Fortrea Clinical Development Private Limited is ₹5.00 M, and the paid-up capital is ₹0.24 M.

What is the compliance status of Fortrea Clinical Development Private Limited?

The compliance status of Fortrea Clinical Development Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available